Sunil Wimalawansa, MD, PhD, MBA, DSc

Professor of Medicine, Endocrinology & Nutrition
Director, Cardiometabolic & Endocrine Institute, (NJ)
Former Chief of Endocrinology, Metabolism & Nutrition at UMDNJ/Rutgers University
Distinguish University Professor,
Former Professor of Medicine, Endocrinology, & Nutrition.
Former Professor of Physiology and Pharmacology at the Graduate School of Biomedical Sciences, Rutgers University

Website: https://www.ama-assn.org/system/files/2019-03/bio-sketch-sunil-wimalawansa_0.pdf
Research Gate: https://www.researchgate.net/profile/Sunil-Wimalawansa
Twitter: @SJWimalawansa
LinkedIn: https://www.linkedin.com/in/sunilwimalawansa/
Email: [email protected]

ABOUT DR. WIMALAWANSA

Sunil Wimalawansa, MD, PhD, MBA, DSc, is a Professor of Medicine, Endocrinology & Nutrition, formerly “University Professor,” Chief of Endocrinology, Metabolism & Nutrition at UMDNJ/Rutgers University, and Professor of Physiology and Pharmacology at the Graduate School of Biomedical Sciences. His Ph.D. was in endocrine receptors and pathology from the University of London, United Kingdom, in 1987. In addition to his medical degrees, he earned a diploma in Medical Administration from Johns Hopkins University School of Business in 2000 and an Executive Master of Business Administration from Rutgers University Business School in 2006.

He has expertise in internal medicine, endocrinology, human nutrition, osteoporosis and metabolic bone diseases, diabetes, obesity, malnutrition, vitamin D, and environmental issues that affect water and sanitation and chronic kidney disease, focusing on disease prevention.

Dr. Wimalawansa is a clinician-scientist with over four decades of experience, a faculty member, medical educator, author, researcher, board member, innovator, administrator, leader, expert witness, and philanthropist. His inventions include vasodilatory CGRP for cardiovascular diseases (prevention of myocardial infarctions, strokes, migraine headaches) and as a treatment for pre-eclamptic toxemia in pregnancy. Concerning musculoskeletal diseases, he invented the once-a-week bisphosphonate use for osteoporosis, combination therapies (anabolic and anti-osteoclastic agents), and nitric oxide regimens for preventing and treating osteoporosis. In 1984, he developed the intra-operative measurement of hormones during surgical procedures, now used worldwide as the standard of care helping millions of patients.

Dr. Wimalawansa has published over 300 peer-reviewed research articles with over 11,000 citations and has written five medical books. He has conducted 250+ medical education-related teaching/training programs in several countries. He delivered over 500 invited national and international lectures and scientific presentations and is the author of the book, “Vitamin D: Everything You Need to Know,” available on Amazon. His recent focus is on micronutrients, especially vitamin D, and optimal ways to use it and its metabolites to prevent and overcome diseases.

INTERVIEW

Dr. Wimalawansa answers top questions about vitamin D during the five-part Q&A series found here:
https://www.grassrootshealth.net/blog/vitamin-d-everything-need-know/

AWARDS & ACCOLADES

Dr. Wimalawansa is a process consultant and Lean Six-Sigma executive and serves on the boards of national and international organizations. He has been a member/consultant of NIH, VA, DEA, and NASA scientific review committees. Dr. Wimalawansa received the Lifetime Achievement Award (2004) from the USA, SL-Foundation for contributions to science and humanity, the Dr. Boy Frame Award for clinical excellence from ASBMR in 1993, and the Oscar Gluck International Humanitarian Award (2008). In 2024, he received the prestigious Eugene T. Davidson, MD, International Public Service Award from AACE for exceptional accomplishments and contributions to medicine and endocrinology.

Dr. Wimalawansa is the first Sri Lankan physician trained in clinical endocrinology and the inventor of live “remote medical consultation clinics,” now known as telemedicine. His legacy of scientific excellence and teaching is evident as he continues positively influencing the future of global health and philanthropy. Dr. Wimalawansa’s visionary leadership and unwavering dedication inspire positive global change and advancements in healthcare.

BOOKS

Vitamin D: Everything You Need to Know

Vitamin D deficiency is an epidemic. Yet majorities of individuals have undiagnosed and untreated vitamin D deficiency. This book enhances the awareness, facilitates understanding the physiology and pathophysiology, adverse health effects, methods of identification of vulnerable populations, and safe and cost-effective regimens for correcting vitamin D deficiency.

PUBLICATIONS

Vitamin D-Related Publications (2012 onwards)—Prof. Sunil J. Wimalawansa
1. Wimalawansa, S.J. Vitamin D in the new millennium [doi 10.1007/s11914-011-0094-8; http://www.ncbi.nlm.nih.gov/pubmed/22249582]. Current Osteoporosis Research
Current Osteoporosis Research, 10(1):4-15, 2012.
2. Wimalawansa, S.J. Vitamin D: What clinicians would like to know. Sri Lanka Journal of Diabetes, Endocrinology, and Metabolism; 2: 73-88, 2012
3. Wimalawansa, S.J. Vitamin D: An essential component for skeletal health. In, Skeletal Biology and Medicine II: Bone and cartilage homeostasis and bone disease, Annals of the New York Academy of Sciences, NY, 2012, 1240(1): E1-12, 2012; doi: 10.1111/j.1749-6632.2011.06374.x
4. Wimalawansa, S.J. Rational food fortification programs to alleviate micronutrient deficiencies. J. Food Process Technol., 4(8): 257-267, 2013; doi:10.4172/2157- 7110.1000257
https://www.omicsonline.org/rational-food-fortification-programs-to-alleviate-micronutrient-deficiencies-2157-7110.1000257.php?aid=17760
https://www.researchgate.net/publication/274551986_Rational_Food_Fortification_Programs_to_Alleviate_Micro-nutrient_Deficiencies
[PDF] Rational Food Fortification Programs to Alleviate Micronutrient Deficiencies | Semantic Scholar
5. Grant, W.B., Wimalawansa, S.J., Holick, M.F., Cannell, J.J., Pludowski, P., Lappe, J.M., Pittaway, M., May, P. Emphasizing the Health Benefits of Vitamin D for Those with Neurodevelopmental Disorders and Intellectual Disabilities, http://www.mdpi.com/2072-6643/7/3/1538, doi:10.3390/nu7031538, Nutrients, 7(3), 1538-1564, 2015.
https://www.scopus.com/record/display.uri?eid=2-s2.0-84924160377&origin=inward&txGid=cc118189991e6e5fe1832ea9a8a9b30b
6. Grant, W.B., Wimalawansa, S.J. Holick, M.F. Vitamin D supplements and reasonable solar UVB should be recommended to prevent the escalating incidence of chronic diseases. doi: BMJ, 2015; 350, h321, 2015.
http://dx.doi.org/10.1136/bmj.h321, http://www.mdpi.com/2072-6643/7/3/1538 http://www.bmj.com/content/350/bmj.h321/rr-1
7. Smith, G. and Wimalawansa, S.J. Reconciling the irreconcilable: Micronutrients in clinical nutrition and public health. http://dx.doi.org/10.4172/ 2376-1318.1000e136, Vitamins and Minerals, 4: 1, 1-4, 2015.
http://www.academia.edu/11797603/Reconciling_the_Irreconcilable_Micronutrients_in_Clinical_Nutrition_and_Public_Health
8. Wimalawansa S.J. Vitamin D deficiency is a surrogate marker for visceral fat content, metabolic syndrome, and future metabolic complications. J Diabetes Metab Disord Control, 3(1): 1-10, 2016. DOI: 10.15406/jdmdc.2016.03.00059 .
http://medcraveonline.com/JDMDC/JDMDC-03-00059.php
https://www.researchgate.net/publication/297735240_Vitamin_D_Deficiency_is_a_Surrogate_Marker_for_Visceral_Fat_Content_Metabolic_Syndrome_Type_2_Diabetes_and_Future_Metabolic_Complications
9. Smith, G., Wimalawansa S.J., Laillou, A, Sophonneary, P., Un, S., Rathavuth Hong, R., Poirot, E., Kuong, K., Chamnan, C., De los Reyes, F., Wieringa, F.T. High Prevalence of Vitamin D deficiencies in Cambodian women: A Common Deficiency in a Sunny Country. Nutrients 2016, 8, 290; doi:10.3390/nu8050290 http://www.mdpi.com/2072-6643/8/5/290/html
10. Wimalawansa, S.J. Vitamin D adequacy and improvements of comorbidities in persons with intellectual developmental disabilities. J. Childhood & Developmental Disorders, 2(3): 22-35, 2016.
http://childhood-developmental-disorders.imedpub.com/vitamin-d-adequacy-and-improvements-of-comorbidities-in-persons-with-intellectual-developmental-disabilities.php?aid=9767
11. Wimalawansa, S.J. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome. https://doi.org/10.1016/j.jsbmb.2016.09.017;
J. Steroid Biochem. Mol. Biol., 175: 177-189, 2016. dx.doi.org/10.1016/j.jsbmb.2016.09.017
https://www.sciencedirect.com/science/article/pii/S0960076016302539
https://ac.els-cdn.com/S0960076016302539/1-s2.0-S0960076016302539-main.pdf?_tid=446f9b7c-fe13-42ac-b4ed-d8588debb982&acdnat=1527324639_f743665c18fe3c60eb6fca644c8fb628
12. Wimalawansa, S.J. Extra-Skeletal benefits, Endocrine Functions, and Toxicity of Vitamin D
(e-Pub; 8.23.2016), J. Endocrinology and Diabetes, 3(3): 1-5, 2016.
http://www.symbiosisonlinepublishing.com/endocrinology-diabetes/endocrinology-diabetes52.pdf
http://dx.doi.org/10.15226/2374-6890/3/3/00152
13. Wimalawansa, S.J. Vitamin D adequacy and improvements of comorbidities in persons with intellectual and developmental disabilities. J. Childhood & Develop Disorders, 2(3): 22-35, 2016.
https://www.researchgate.net/publication/310457227_Vitamin_D_Adequacy_and_Improvements_of_Comorbidities_in_Persons_with_Intellectual_and_Developmental_Disabilities
14. Haq A., Wimalawansa S.J., Pludowski P., Al, Fatme. Clinical practice guidelines for vitamin D in the United Arab Emirates. J. Steroid Biochem. and Mol. Biol., 175, 4-11, 2016.
http://dx.doi.org/10.1016/j.jsbmb.2016.09.021
https://www.sciencedirect.com/science/article/pii/S0960076016302576
15. Haq A., Svobodová, J., Sofim N.Y., Jindrova, A., Kába, B., Rajah, J., Anouti, A, Al., Abdel-Wareth, L., Wimalawansa S.J., Razzaque, M.S. Vitamin D status among the juvenile population: A retrospective study.10.1016/j.jsbmb.2017.01.005, J. Steroid Biochem. Mol. Biol., 175: 49-54, 2018.
https://www.sciencedirect.com/science/article/pii/S0960076017300055
16. Pludowski, P., Holick, M.F., Grant, W.B., Konstantynowicz, J., Mascarenhas, M.R., Haq, A., Povoroznyuk, V., Balatska, N., Barbosa, A.P., Karonova, Rudenka, E., Misiorowski, Q., Zakharova, I., Rudenka, A., Łukaszkiewicz, J., Marcinowska-Suchowierska, E., Łaszcz, N., Abramowicz, P., Bhattoa, H.P., Wimalawansa, S.J. Vitamin D supplementation guidelines.
dx.doi.org/10.1016/j.jsbmb.2017.01.021; J. Steroid Biochem. Mol. Biol., 175: 125-135, 2018.
https://www.sciencedirect.com/science/article/pii/S0960076017300316
file:///C:/Users/Sunil/Desktop/PludowskiHolickGrantVitDsupplementationguidelinesJSBMB2018.pdf
17. Haq A., Wimalawansa S.J., Carlberg, C. Highlights from the 5th International Conference on Vitamin D Deficiency, Nutrition and Human Health, Abu Dhabi, United Arab Emirates, March 24-25, 2016. dx.doi.org/10.1016/j.jsbmb.2017.04.008; J. Steroid Biochem. Mol. Biol., 175: 1-3, 2018.
https://www.sciencedirect.com/science/article/pii/S0960076017301073
https://www.sciencedirect.com/science/article/pii/S0960076017301073?via%3Dihub
https://www.sciencedirect.com/journal/the-journal-of-steroid-biochemistry-and-molecular-biology/vol/175
18. Wimalawansa, S.J. Vitamin D and cardiovascular diseases: Causality. J. Steroid Biochem. Mol. Biol., 175: 29-43, 2018; dx.doi.org/10.1016/j.jsbmb.2016.12.016
https://www.sciencedirect.com/science/article/pii/S0960076016303636
19. Wimalawansa, S.J., Razzeque, M.S., Al-Daghri, N.M., Calcium vitamin D on human health; Hype or real? Steroid Biochemistry and Molecular Biology (published online, 16th Dec. 2017):
https://doi.org/10.1016/j.jsbmb.2017.12.009 ; SBMB, 180: 4-14, 2018.
http://www.sciencedirect.com/science/article/pii/S0960076017303813
20. Al-Daghri, NM, Ansari, MGA, Sabico, S, Al-Saleh, Y, Aljohani, NJ, Alfawaz, H, Alharbi, M,
Al-Othman, AM, Alokail, MS, Wimalawansa, SJ. Efficacy of different modes of vitamin D supplementation strategies in Saudi adolescents. Steroid Biochem, Mol Biology, 2018. SBMB, 180: 23-28, 2018. https://doi.org/10.1016/j.jsbmb.2018.02.002
https://www.sciencedirect.com/science/article/pii/S0960076018300633
21. Wimalawansa, S.J. Non-musculoskeletal Benefits of Vitamin D. J. Steroid Biochem. Mol. Biol., 175: 60-81, 2016. DOI: 10.1016/j.jsbmb.2016.09.016; 175: 60-81, 2018.
http://www.sciencedirect.com/science/article/pii/S0960076016302527
22. Heyden, E.L., Wimalawansa, S.J., Vitamin D: Effects on human reproduction, pregnancy, and fetal well-being. Steroid Biochemistry and Molecular Biology (published online, Dec 2017). DOI10.1016/j.jsbmb.2017.12.011; SBMB, 180: 41-50, 2018.
https://www.sciencedirect.com/science/article/pii/S0960076017303825
23. Al-Musharaf, S, Fouda, MA,Turkestani, IZ, Al-Ajlan, A, Sabico, S, Alnaami, AM, Wani, K, Hussain, SD, Alraqebah, B, Al-Serehi, A, Alshingetti, NM, Al-Daghri, N, McTernan, PG, Wimalawansa, S.J., Saravanan, P. Vitamin D deficiency Prevalence and predictors in early pregnancy among Arab women. Nutrients, 2018, 10, 489, 2012; doi:10.3390/nu10040489
https://www.ncbi.nlm.nih.gov/pubmed/29662044
24. Heyden, E.L., Wimalawansa, S.J., Vitamin D deficiency-related reproductive consequences.
Sci J. of Gyne and Obste. 2(1): 1-6, 2019.
http://onomyscience.com/onomy/articles/SJGO-ID-08.pdf;
25. Wimalawansa, S.J. Vitamin D Deficiency: Effects on Oxidative Stress, Epigenetics, Gene Regulation, and Aging. Biology 2019, 8(2), 30; 1-15; DOI: 10.3390/biology8020030.
https://www.mdpi.com/2079-7737/8/2/30. [https://www.mdpi.com/journal/biology/special_issues/Mitochondria]
26. Wolf, T.A., Wimalawansa, S.J., Razzaque, M.S., Procalcitonin as a biomarker of critically ill patients with sepsis: Effects of vitamin D supplementation. Journal of Steroid Biochemistry and Molecular Biology, 2019. 193:105428, 2019: DOI: 10.1016/j.jsbmb.2019.105428
27. Wimalawansa. S.J., Biology of Vitamin D. J Steroids & Horm Sci., 10:198 p 1-8, 2019.
doi: 10.24105/2157-7536.10.198.
www.longdom.org/open-access/biology-of-vitamin-d.pdf. https://lnkd.in/ggxFE5nr.
https://www.sciencedirect.com/science/article/pii/S2405844019359699
28. Wimalawansa, S.J., Disease prevention strategies using vitamin D. Adv. Health Behav., 2(2): 96-100, 2019; DOI: 10.25082/AHB.2019.02.005
https://www.syncsci.com/journal/index.php/AHB/article/view/374/297
29. Wimalawansa, S.J. Causes, consequences and ways of correcting vitamin D deficiency.
Nutrition And Food Science Journal (Scientific Literature), 2(1):122, 1-8, 2019.
Nutrition-19-122.pdf (scientificliterature.org).
30. Wimalawansa, S.J., Prevention of chronic diseases by maintaining physiological concentrations of vitamin D. J. Clin. Endocrine. Diab. Res., 1(1); 1-3, 2019.
https://www.jresearchvalley.com/articles/prevention-of-chronic-diseases-by-maintaining-physiologicalnbspconcentrations-of-vitamin-d.html
31. Wimalawansa, S.J., Global epidemic of coronavirus—COVID-19: What can we do to minimize risks? European J. Biomed & Pharma Sci. (EJBPS), 7(3), 432-438, 2020.
https://storage.googleapis.com/journal-uploads/ejbps/article_issue/volume_7_march_issue_3/1679640839.pdf
32. Wimalawansa, S.J., Fighting against COVID-19: Boosting the immunity with micronutrients, stress reduction, physical activity, and vitamin D. Nutrition and Food Science Journal, 3(1):126: 1-4, 2020.
33. Wimalawansa, S.J., Modes of preventing secondary community spread, and future epidemics of COVID-19. J. Immuno Biol., 5:1, 1-5, 2020. DOI: 10.37421/JIB.2020.5.147
34. Wimalawansa, S.J., COVID-19: Evolution and Prevention. Trends Telemed E-Health
TTEH: 000539, 2(3): 1-5, 2020. DOI: 10.31031/TTEH.2020.02.000539
https://crimsonpublishers.com/tteh/pdf/TTEH.000539.pdf
35. Wimalawansa, S.J., Strengthen the immune system with nutrients to overcome COVID-19 infection. Endocrinology & Metabolic Research, 5(8): 1-7, 2020;
https://www.researchgate.net/publication/344461310_Strengthen_the_Immune_System_with_Nutrients_to_Overcome_COVID-19_Infection
36. Wimalawansa, S.J., Commonsense approach to minimizing risks from COVID-19. Open J Pulm Respir Med., 2: 28-37, 2020. DOI: 10.36811/ojprm.2020.110010.
https://www.raftpubs.com/ojprm-pulmonology-and-respiratory-medicine/articles/ojprm_raft1010.php
37. Wimalawansa, S.J., Current status and prevention of COVID-19What do we know? Arch Health Sci; 4(1): 1-7, 2020. DOI: 10.31829/2641-7456/ahs2020-4(1)-143
https://gudapuris.com/articles/10.31829-2641-7456-ahs2020-4(1)-143.pdf
38. Wimalawansa, S.J., Reducing risks from COVID-19: Cost-effective ways of strengthening individual’s and the population immunity with vitamin D. J Endocrinol Sci.; 2(2) :5-13, 2020.
https://www.endocrinoljournal.com/articles/reducing-risks-from-covid-19-cost-effective-ways-of-strengthening-individuals-and-the-population-immunity-with-vitamin-d.html
39. Wimalawansa, S.J., Protecting from COVID-19 through strengthening innate immunity. Diabetes Res Metab.;1(10): 104-106, 2020. DOI: gsl.drm.2020.000104
40. Himani, K.R, Haq, A, Wimalawansa, S.J, Sharma, A., Putative Roles of Vitamin D in Modulating immune response and immunopathology associated with COVID-19.
Virus Research, 198235, 2020, DOI: 10.1016/j.virusres.2020.198235;
https://pubmed.ncbi.nlm.nih.gov/33232783/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680047/pdf/main.pdf
41. Wimalawansa, S.J. Achieving population vitamin D sufficiency will markedly reduce
healthcare costs. EJBPS, 2020, Volume 7, Issue 3, 136-141.
1591617368.pdf (storage.googleapis.com)
42. Wimalawansa, S.J., Controlling COVID-19 pandemic with cholecalciferol.
World Journal of Advance Healthcare Research 5(1), 155-165, 2020. ISSN: 2457-0400
DOI: https://doi.org/10.17605/OSF.IO/7UQ6P
https://wjahr.com/admin/assets/article_issue/25122020/1610357512.pdf
43. Wimalawansa, S.J., Maintaining optimum health requires longer-term stable vitamin D concentrations. Science Repository: International J. Regenerative Medicine. 3:(3), 1-5, 2020. doi. 10.31487/j.RGM.2020.03.03 (ISSN 2613-5914):
https://www.sciencerepository.org/maintaining-optimum-health-requires-longer-term-stable-vitamin_RGM-2020-3-103.
44. Wimalawansa, S.J., Minimize Risks of COVID-19 Infection. J Biomed Res Environ Sci., 1(8): 427-430, 2020. DOI: 10.37871/jbres1174, Article ID: JBRES1174
https://www.jelsciences.com/articles/jbres1174.pdf
45. Wimalawansa. S.J., Effective and practical ways to overcome vitamin D deficiency.
J Family Med Community Health. 8(1): 1-8, 2021.
https://www.jscimedcentral.com/FamilyMedicine/familymedicine-7-1170.pdf
46. Wimalawansa. S.J., ACE inhibitors and angiotensin receptor blockers reduce the complications associated with COVID-19 infection. World J. Pharmaceutical Research,
10(3), 2579-2600, 2021. https://doi.org/10.17605/OSF.IO/2ME36,
https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/1619675774.pdf.
47. Wimalawansa, S.J., The cost-effective options in combating COVID-19. Biomed Res., Biomedical Applications in Health Science, S21- S23, 2021, (ISSN 0970-938X).
Biomedical Research:
https://www.alliedacademies.org/articles/the-costeffective-options-in-combating-covid19.pdf
48. Wimalawansa, S.J. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections—Sepsis and COVID-19. Nutrients, 14(14), 2997, 2022. https://doi.org/10.3390/nu14142997
https://www.mdpi.com/2072-6643/14/14/2997
Full text: https://www.mdpi.com/2072-6643/14/14/2997/htm
49. Wimalawansa, S.J., Overcoming Infections Including COVID-19, by Maintaining Circulating 25(OH)D Concentrations Above 50 ng/mL. Pathology and Laboratory Medicine International. Pathology and Laboratory Medicine Int., 14, 37—60, 2022. DOI: 10.2147/PLMI.S373617
https://doi.org/10.2147/PLMI.S373617
50. Wimalawansa, S.J. Prophylactic use of vitamin D to maintain a robust immune system against infections like SARS-CoV-2. Glob J Endocrinol Metab 3(5). GJEM. 000571. 2023. DOI:
https://doi.org/10.31031/GJEM.2023.03.000571
https://crimsonpublishers.com/gjem/pdf/GJEM.000571.pdf
51. Wimalawansa, S.J. Physiological basis for using vitamin D to improve health. Biomedicines 11, 1542. 2023. https://www.mdpi.com/2227-9059/11/6/1542
https://doi.org/10.3390/biomedicines11061542
52. Wimalawansa, S.J. Vitamin D: Cost-effectively overcome infections and chronic diseases. Aug. 2023, DOI: 10.3390/nu15163623
https://encyclopedia.pub/entry/48753
53. Wimalawansa, S.J. Controlling Chronic Diseases and acute infections with vitamin D sufficiency. Nutrients 2023, 15, 3623. https://doi.org/10.3390/nu15163623.
https://www.mdpi.com/2072-6643/15/16/3623
54. Polonovita, AK and Wimalawansa, S.J. Molecular quantum and logic process of consciousness—Vitamin D big-data in covid-19—a case for incorporating machine learning in medicine. EJPBS, 10(12), 24-43, 2023. DOI: 10.5281/zenodo.10435649
https://storage.googleapis.com/journal-uploads/ejbps/article_issue/volume_10_december_issue_12/1702368786.pdf.
55. Wimalawansa, S.J. Infections and Autoimmunity—The immune system and vitamin D:
A systematic review. Nutrients 2023, 15, 1-33. 3842.
https://doi.org/10.3390/nu15173842
56. Polonowita, AK and Wimalawansa, S.J. The impact of withholding cost-effective early treatments, such as vitamin D, on COVID-19: An analysis using an innovative logical paradigm.
World J. Adv. Pharma. Life Sci., 05(2); 13–34, 2023.
doi.org/10.53346/wjapls.2023.5.2.0080
https://zealjournals.com/wjapls/content/impact-withholding-cost-effective-early-treatments-such-vitamin-d-covid-19-analysis-using
57. Wimalawansa, S.J. Decoding the paradox: Understanding elevated hospitalization and reduced mortality in SARS-CoV-2 variants. Int J Frontiers in Sci and Technol Res., 6(2): 1-20, 2024. DOI: 10.53294/ijfstr.2024.6.2.0031
https://frontiersrj.com/journals/ijfstr/sites/default/files/IJFSTR-2024-0031.pdf
58. Wimalawansa, S.J. Physiology of vitamin D—Focusing on disease prevention. Nutrients 2024, 16(11), 1666; https://doi.org/10.3390/nu16111666
https://www.mdpi.com/2072-6643/16/11/1666.